Literature DB >> 3230472

Pharmacological effects of urapidil on bronchospasm, myocardial hypoxia and postural hypotension in experimental animals.

T Murai1, K Sanai, Y Miyao, T Kanai.   

Abstract

We studied the effects of urapidil on bronchospasm, myocardial hypoxia and postural hypotension in experimental animals. Urapidil dose-dependently inhibited bronchospasm induced by histamine in anaesthetized guinea pigs and the contraction of isolated trachea induced by noradrenaline or phenylephrine. Urapidil markedly delayed the appearance of severe dyspnoea induced by histamine aerosol in guinea pigs. Further, urapidil inhibited isoproterenol-induced ST depression in rats and inhibited histamine-induced ST depression in rabbits. The postural hypotension induced by prazosin was greater than that induced by urapidil in equihypotensive doses in conscious rabbits. Urapidil induced a lesser alpha-blockade in the vein than in the artery compared with prazosin. These combined properties of urapidil suggest that the drug is worth investigation in hypertensive patients with bronchial asthma or ischaemic heart disease.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3230472

Source DB:  PubMed          Journal:  J Hypertens Suppl        ISSN: 0952-1178


  3 in total

1.  Acute effects of urapidil on airway response in hypertensive patients with chronic obstructive pulmonary disease.

Authors:  M Cazzola; A Spinazzi; G Santangelo; V W Steinijans; W Wurst; P Solleder; G Girbino
Journal:  Drugs       Date:  1990       Impact factor: 9.546

Review 2.  Urapidil. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in the treatment of hypertension.

Authors:  H D Langtry; G J Mammen; E M Sorkin
Journal:  Drugs       Date:  1989-12       Impact factor: 9.546

3.  The vagal ganglia transcriptome identifies candidate therapeutics for airway hyperreactivity.

Authors:  Leah R Reznikov; David K Meyerholz; Mahmoud Abou Alaiwa; Shin-Ping Kuan; Yan-Shin J Liao; Nicholas L Bormann; Thomas B Bair; Margaret Price; David A Stoltz; Michael J Welsh
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2018-04-05       Impact factor: 5.464

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.